Skip to main content

Effectiveness of myAirCoach: a mHealth self-management system in asthma

Khusial, Rishi J.; Honkoop, Persijn J.; Usmani, Omar; Soares, Marcia; Simpson, Andrew; Biddiscombe, Martyn; Meah, Sally; Bonini, Matteo; Lalas, Antonios; Polychronidou, Eleftheria; Koopmans, Julia G.; Moustakas, Kostas; Snoeck-Stroband, Jiska B.; Ortmann, Steffen; Votis, Konstantinos; Tzovaras, Dimitrios; Chung, Kian Fan; Fowler, Stephen; Sont, Jacob K.

Authors

Rishi J. Khusial

Persijn J. Honkoop

Omar Usmani

Marcia Soares

Martyn Biddiscombe

Sally Meah

Matteo Bonini

Antonios Lalas

Eleftheria Polychronidou

Julia G. Koopmans

Kostas Moustakas

Jiska B. Snoeck-Stroband

Steffen Ortmann

Konstantinos Votis

Dimitrios Tzovaras

Kian Fan Chung

Stephen Fowler

Jacob K. Sont



Abstract

Background
Self-management programs have beneficial effects on asthma control, but their implementation in clinical practice is poor. Mobile health (mHealth) could play an important role in enhancing self-management.

Objective
To assess the clinical effectiveness and technology acceptance of myAirCoach supported self-management on top of usual care in asthma patients using inhalation medication .

Methods
Patients were recruited in two separate studies. The myAirCoach system consisted of an inhaler adapter, an indoor air-quality monitor, a physical activity tracker, a portable spirometer, a Fraction exhaled Nitric Oxide (FeNO) device and an app. The primary outcome was asthma control; secondary outcomes were exacerbations, quality of life, and technology acceptance. In study 1, 30 participants were randomized to either usual care or myAirCoach support for 3-6 months; in study 2, 12 participants were provided with the myAirCoach system in a 3 month before-after study.

Results
In study 1 asthma control improved in the intervention group compared to controls (ACQ difference 0.70, p=0.006). A total of six exacerbations occurred in the intervention group compared to 12 in the control group (hazard ratio 0.31, p=0.06). Asthma related quality of life improved (m-AQLQ difference 0.53, p= 0.04), but FEV1 was unchanged. In study 2, asthma control improved by 0.86 compared to baseline (p=0.007) and quality of life by 0.16 (p=0.64). Participants reported positive attitudes towards the system.

Discussion
Using the myAirCoach support system improves asthma control and quality of life, with a reduction in severe asthma exacerbations. Well validated mHealth technologies should therefore be further studied.

Journal Article Type Article
Journal The Journal of Allergy and Clinical Immunology: In Practice
Print ISSN 2213-2198
Peer Reviewed Peer Reviewed
APA6 Citation Khusial, R. J., Honkoop, P. J., Usmani, O., Soares, M., Simpson, A., Biddiscombe, M., …Sont, J. K. (in press). Effectiveness of myAirCoach: a mHealth self-management system in asthma. The journal of allergy and clinical immunology. In practice, https://doi.org/10.1016/j.jaip.2020.02.018
DOI https://doi.org/10.1016/j.jaip.2020.02.018
Keywords Immunology and Allergy; asthma; mHealth; app; eHealth; telemedicine; self-management; quality of life; personalized care

Files

Pre-proof (1.4 Mb)
PDF

Copyright Statement
© 2020 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology





You might also like



Downloadable Citations

;